Sign in
4

Changes in Ownership

RxSight, Inc. Filed Acc 0000950170-24-053667

President & CEO sold 40,000 shares at $60.15 ($2,405,872)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kurtz Ronald M MD President & CEO 2024-05-03 Sale 10b5-1 −40,000 $60.15 $2,405,872 764,610 I: show line 1 in the form
Open-market sales · 40,000 sh · avg $60.15 · $2,405,872
Loading xslF345X05/ownership.xml…